Allelic fractions correlated significantly with status (Table 6), pancreatic cancer cases carrying cfDNA KRAS mutations at higher allelic fractions than patients with chronic pancreatitis (t-test on log10(allelic fractions) p=0.0259) and healthy controls (p=0.0008). Here, KRAS is linked to familial pancreatic carcinoma.